SCHEMBL288439

SCHEMBL288439

NC(N)CCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4451551 0.97 ENPEP (0.58)
Hydrochloric Acid SCHEMBL20742887 0.97 ENPEP (0.58)
SCHEMBL500127 0.92 ENPEP (0.61)
SCHEMBL287721 0.90 ALDH1A1 (0.61)
SCHEMBL10872728 0.90 ALDH1A1 (0.61)
SCHEMBL289225 0.90 ALDH1A1 (0.61)
Adipic Acid SCHEMBL28394840 0.85 NFKB1 (0.65)
Adipic Acid SCHEMBL27807130 0.84 AKR1B1 (0.62)
Adipic Acid SCHEMBL28544733 0.84 AKR1B1 (0.62)
SCHEMBL27963271 0.83 ENPEP (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532509-A1 INSOLUBLE SUPPORT FOR SOLID PHASE SYNTHESIS Polypeptide Laboratories Holding (PPL) AB (SE) 2025-04-09 EP claimed
EP-4392010-A1 ORAL CARE COMPOSITIONS FOR GUM HEALTH The Procter & Gamble Company (US) 2024-07-03 EP claimed
EP-4391992-A1 ORAL CARE COMPOSITIONS FOR GUM HEALTH The Procter & Gamble Company (US) 2024-07-03 EP claimed
EP-4373836-A1 COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MicuRx Pharmaceutical Co., Ltd. (CN) 2024-05-29 EP claimed
EP-4312981-A1 EDIBLE ORAL COMPOSITIONS COMPRISING HOPS The Procter & Gamble Company (US) 2024-02-07 EP claimed
EP-4312956-A1 ORAL CARE COMPOSITIONS COMPRISING HOPS AND SWEETENER The Procter & Gamble Company (US) 2024-02-07 EP claimed
WO-2023234837-A1 INSOLUBLE SUPPORT FOR SOLID PHASE SYNTHESIS POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) 2023-12-07 WO claimed
EP-4216915-A1 ORAL CARE COMPOSITION COMPRISING HOPS AND FLAVOR The Procter & Gamble Company (US) 2023-08-02 EP claimed
WO-2023023884-A1 ORAL CARE COMPOSITIONS FOR GUM HEALTH THE PROCTER & GAMBLE COMPANY (US) 2023-03-02 WO claimed
WO-2023023886-A1 ORAL CARE COMPOSITIONS FOR GUM HEALTH THE PROCTER & GAMBLE COMPANY (US) 2023-03-02 WO claimed
CN-111574682-A Waterborne polyurethane dispersant and color paste containing same for textile digital printing 珠海中墨科技有限公司 2020-08-25 CN claimed
CN-111320738-A Polyurethane dispersant, preparation method thereof and color paste 珠海中墨科技有限公司 2020-06-23 CN claimed
CN-107021952-B A kind of different luminol derivative and its preparation method and application 深圳市新产业生物医学工程股份有限公司 2019-09-17 CN claimed
CN-102216279-A Phenyl pyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof TOPHARMAN SHANGHAI CO LTD 2011-10-12 CN claimed
WO-2011011631-A2 NUCLEIC ACID DELIVERY VEHICLES ZALIPSKY SAMUEL (US) 2011-01-27 WO claimed
CN-1320878-C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor WOMEN FIRST HEALTHCARE INC (US) 2007-06-13 CN claimed
CN-1093755-C Topical composition for inhibiting hair growth GILLETTE CO (US) 2002-11-06 CN claimed
CN-1045160-C Hair growth modification agent JOHNSEF H HANDAERMAN (US) 1999-09-22 CN claimed
CN-1097982-A Topical compositions for inhibiting hair growth HANDELMAN JOSEPH H (US) 1995-02-01 CN claimed
CN-85108498-A Hair growth modification agent 1986-06-10 CN claimed